These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 36691569)
1. CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma. Romero-Cristóbal M; Clemente-Sánchez A; Ramón E; Téllez L; Canales E; Ortega-Lobete O; Velilla-Aparicio E; Catalina MV; Ibáñez-Samaniego L; Alonso S; Colón A; Matilla AM; Salcedo M; Albillos A; Bañares R; Rincón D JHEP Rep; 2023 Mar; 5(3):100645. PubMed ID: 36691569 [TBL] [Abstract][Full Text] [Related]
2. Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma. Souhami A; Sartoris R; Rautou PE; Cauchy F; Bouattour M; Durand F; Giannelli V; Gigante E; Castera L; Valla D; Soubrane O; Vilgrain V; Ronot M JHEP Rep; 2020 Oct; 2(5):100147. PubMed ID: 32885156 [TBL] [Abstract][Full Text] [Related]
3. Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history. Romero-Cristóbal M; Clemente-Sánchez A; Peligros MI; Ramón E; Matilla AM; Colón A; Alonso S; Catalina MV; Fernández-Yunquera A; Caballero A; García R; López-Baena JÁ; Salcedo MM; Bañares R; Rincón D United European Gastroenterol J; 2022 Oct; 10(8):805-816. PubMed ID: 36065767 [TBL] [Abstract][Full Text] [Related]
15. Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension. Azoulay D; Ramos E; Casellas-Robert M; Salloum C; Lladó L; Nadler R; Busquets J; Caula-Freixa C; Mils K; Lopez-Ben S; Figueras J; Lim C JHEP Rep; 2021 Feb; 3(1):100190. PubMed ID: 33294830 [TBL] [Abstract][Full Text] [Related]
16. The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data. Hong WK; Kim MY; Baik SK; Shin SY; Kim JM; Kang YS; Lim YL; Kim YJ; Cho YZ; Hwang HW; Lee JH; Chae MH; Kim HA; Kang HW; Kwon SO Clin Mol Hepatol; 2013 Dec; 19(4):370-5. PubMed ID: 24459641 [TBL] [Abstract][Full Text] [Related]
17. Non-Invasive Diagnostic Tests for Portal Hypertension in Patients with HBV- and HCV-Related Cirrhosis: A Comprehensive Review. Celsa C; Veneziano M; Di Giorgio FM; Cannova S; Lombardo A; Errigo E; Landro G; Simone F; Sinagra E; Calvaruso V Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792873 [TBL] [Abstract][Full Text] [Related]
18. Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India. Kumar A; Khan NM; Anikhindi SA; Sharma P; Bansal N; Singla V; Arora A World J Gastroenterol; 2017 Jan; 23(4):687-696. PubMed ID: 28216976 [TBL] [Abstract][Full Text] [Related]
19. [Risk factors of clinically significant portal hypertension in patients with compensated liver cirrhosis based on hepatic venous pressure gradient]. Jiang FR; Yan HD Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):995-1000. PubMed ID: 34814395 [No Abstract] [Full Text] [Related]
20. Non-invasive liver disease assessment to identify portal hypertension: A systematic review supporting the AASLD Practice Guideline. Rockey DC; Alsawas M; Duarte-Rojo A; Patel K; Levine D; Asrani SK; Hasan B; Nayfeh T; Alsawaf Y; Saadi S; Malandris K; Murad MH; Sterling RK Hepatology; 2024 Mar; ():. PubMed ID: 38489516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]